Skip to main content
OpenTrials

Clinical trial condition

Systemic Lupus Erythematosus (SLE)

Explore clinical trials studying Systemic Lupus Erythematosus (SLE). Study availability and eligibility vary by location and protocol.

97 public trials 45 recruiting studies
Refine in advanced search Browse all conditions

Systemic Lupus Erythematosus (SLE) trial results

Completed

A Study to Investigate the Safety and Efficacy of Elsubrutinib and Upadacitinib Given Alone or in Combination in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE)

NCT03978520

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • Arizona Arthritis & Rheumatology Research, PLLC /ID# 214522 Mesa, Arizona, United States
  • AZ Arthritis and Rheumotology Research, PLLC /ID# 211329 Phoenix, Arizona, United States
  • AZ Arthritis and Rheumotology Research, PLLC /ID# 214267 Phoenix, Arizona, United States
  • Arthritis and Rheumatism Associates /ID# 211411 Jonesboro, Arkansas, United States
View all 160 locations
View Trial Details
Completed

Omega-3 Replacement With Krill Oil in Disease Management of SLE

NCT03626311

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Wallace Rheumatic Studies Center, LLC Beverly Hills, California, United States
  • UC Irvine Health Orange, California, United States
  • University of Miami Miami, Florida, United States
View all 19 locations
View Trial Details
Completed

A Phase 2 Efficacy and Safety Study of Dapirolizumab Pegol (DZP) in Systemic Lupus Erythematosus

NCT02804763

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • Sl0023 312 Birmingham, Alabama, United States
  • Sl0023 307 El Cajon, California, United States
  • Sl0023 309 El Cajon, California, United States
  • Sl0023 323 Huntington Beach, California, United States
View all 71 locations
View Trial Details
Completed

Acthar for the Treatment of Systemic Lupus Erythematosus (SLE) in Patients With a History of Persistently Active Disease

NCT01753401

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • Mallinckrodt Investigational Site Jonesboro, Arkansas, United States
  • Mallinckrodt Investigational Site La Jolla, California, United States
  • Mallinckrodt Investigational Site La Palma, California, United States
  • Mallinckrodt Investigational Site Long Beach, California, United States
View all 22 locations
View Trial Details

Related conditions